Logo image of CBZ

CBIZ INC (CBZ) Stock Fundamental Analysis

NYSE:CBZ - New York Stock Exchange, Inc. - US1248051021 - Common Stock - Currency: USD

78.17  +0.06 (+0.08%)

After market: 78.2 +0.03 (+0.04%)

Fundamental Rating

4

Taking everything into account, CBZ scores 4 out of 10 in our fundamental rating. CBZ was compared to 82 industry peers in the Professional Services industry. CBZ has only an average score on both its financial health and profitability. CBZ is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CBZ had positive earnings in the past year.
In the past year CBZ had a positive cash flow from operations.
Each year in the past 5 years CBZ has been profitable.
CBZ had a positive operating cash flow in each of the past 5 years.
CBZ Yearly Net Income VS EBIT VS OCF VS FCFCBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a decent Return On Assets value of 5.58%, CBZ is doing good in the industry, outperforming 60.76% of the companies in the same industry.
CBZ has a Return On Equity of 12.83%. This is comparable to the rest of the industry: CBZ outperforms 59.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.98%, CBZ is in line with its industry, outperforming 51.90% of the companies in the same industry.
Industry RankSector Rank
ROA 5.58%
ROE 12.83%
ROIC 6.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBZ Yearly ROA, ROE, ROICCBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBZ's Profit Margin of 7.08% is fine compared to the rest of the industry. CBZ outperforms 74.68% of its industry peers.
In the last couple of years the Profit Margin of CBZ has declined.
CBZ's Operating Margin of 9.71% is fine compared to the rest of the industry. CBZ outperforms 73.42% of its industry peers.
CBZ's Operating Margin has declined in the last couple of years.
CBZ has a worse Gross Margin (13.83%) than 87.34% of its industry peers.
CBZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.71%
PM (TTM) 7.08%
GM 13.83%
OM growth 3Y-24.22%
OM growth 5Y-13.69%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-11.3%
GM growth 5Y-5.24%
CBZ Yearly Profit, Operating, Gross MarginsCBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBZ is destroying value.
CBZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBZ Yearly Shares OutstandingCBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
CBZ Yearly Total Debt VS Total AssetsCBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.77 indicates that CBZ is not in any danger for bankruptcy at the moment.
CBZ has a better Altman-Z score (3.77) than 70.89% of its industry peers.
The Debt to FCF ratio of CBZ is 2.24, which is a good value as it means it would take CBZ, 2.24 years of fcf income to pay off all of its debts.
CBZ has a better Debt to FCF ratio (2.24) than 67.09% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that CBZ is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.36, CBZ is in line with its industry, outperforming 48.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.24
Altman-Z 3.77
ROIC/WACC0.79
WACC8.82%
CBZ Yearly LT Debt VS Equity VS FCFCBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.49 indicates that CBZ should not have too much problems paying its short term obligations.
The Current ratio of CBZ (1.49) is comparable to the rest of the industry.
CBZ has a Quick Ratio of 1.49. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
CBZ has a Quick ratio (1.49) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.49
Quick Ratio 1.49
CBZ Yearly Current Assets VS Current LiabilitesCBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

7

3. Growth

3.1 Past

CBZ shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.56%.
The Earnings Per Share has been growing by 15.05% on average over the past years. This is quite good.
Looking at the last year, CBZ shows a quite strong growth in Revenue. The Revenue has grown by 13.97% in the last year.
The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)7.56%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%23.08%
Revenue 1Y (TTM)13.97%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%40.52%

3.2 Future

Based on estimates for the next years, CBZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.99% on average per year.
CBZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.21% yearly.
EPS Next Y21.32%
EPS Next 2Y15.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.55%
Revenue Next 2Y25.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CBZ Yearly Revenue VS EstimatesCBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
CBZ Yearly EPS VS EstimatesCBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

CBZ is valuated quite expensively with a Price/Earnings ratio of 30.54.
Compared to the rest of the industry, the Price/Earnings ratio of CBZ indicates a slightly more expensive valuation: CBZ is more expensive than 60.76% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.98. CBZ is around the same levels.
A Price/Forward Earnings ratio of 25.17 indicates a quite expensive valuation of CBZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBZ is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CBZ to the average of the S&P500 Index (22.66), we can say CBZ is valued inline with the index average.
Industry RankSector Rank
PE 30.54
Fwd PE 25.17
CBZ Price Earnings VS Forward Price EarningsCBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

62.03% of the companies in the same industry are cheaper than CBZ, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBZ is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 26.02
EV/EBITDA 21.18
CBZ Per share dataCBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

CBZ's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 15.99% in the coming years.
PEG (NY)1.43
PEG (5Y)2.03
EPS Next 2Y15.99%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBZ!.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (2/28/2025, 8:04:00 PM)

After market: 78.2 +0.03 (+0.04%)

78.17

+0.06 (+0.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)04-23 2025-04-23/bmo
Inst Owners91.53%
Inst Owner Change2.06%
Ins Owners4.04%
Ins Owner Change-3.34%
Market Cap3.92B
Analysts85.71
Price Target98.94 (26.57%)
Short Float %2.83%
Short Ratio4.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.79%
Min EPS beat(2)-43.49%
Max EPS beat(2)9.91%
EPS beat(4)3
Avg EPS beat(4)-7.04%
Min EPS beat(4)-43.49%
Max EPS beat(4)9.91%
EPS beat(8)5
Avg EPS beat(8)-3.62%
EPS beat(12)8
Avg EPS beat(12)-7.05%
EPS beat(16)12
Avg EPS beat(16)7.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.62%
Revenue beat(4)1
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)4.95%
Revenue beat(8)5
Avg Revenue beat(8)1.55%
Revenue beat(12)9
Avg Revenue beat(12)3.24%
Revenue beat(16)13
Avg Revenue beat(16)3.8%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 25.17
P/S 2.33
P/FCF 26.02
P/OCF 23.86
P/B 4.23
P/tB N/A
EV/EBITDA 21.18
EPS(TTM)2.56
EY3.27%
EPS(NY)3.11
Fwd EY3.97%
FCF(TTM)3
FCFY3.84%
OCF(TTM)3.28
OCFY4.19%
SpS33.49
BVpS18.49
TBVpS-2.04
PEG (NY)1.43
PEG (5Y)2.03
Profitability
Industry RankSector Rank
ROA 5.58%
ROE 12.83%
ROCE 9.71%
ROIC 6.98%
ROICexc 6.99%
ROICexgc 18.07%
OM 9.71%
PM (TTM) 7.08%
GM 13.83%
FCFM 8.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-24.22%
OM growth 5Y-13.69%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-11.3%
GM growth 5Y-5.24%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.24
Debt/EBITDA 1.68
Cap/Depr 36.06%
Cap/Sales 0.81%
Interest Coverage 250
Cash Conversion 81.74%
Profit Quality 126.66%
Current Ratio 1.49
Quick Ratio 1.49
Altman-Z 3.77
F-Score6
WACC8.82%
ROIC/WACC0.79
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)173.58%
Profit Quality(5y)173.15%
High Growth Momentum
Growth
EPS 1Y (TTM)7.56%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%23.08%
EPS Next Y21.32%
EPS Next 2Y15.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.97%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%40.52%
Revenue Next Year25.55%
Revenue Next 2Y25.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-7.69%
EBIT growth 3Y-10.61%
EBIT growth 5Y-1.75%
EBIT Next Year77.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.26%
FCF growth 3Y0.41%
FCF growth 5Y7.97%
OCF growth 1Y33.32%
OCF growth 3Y-1.95%
OCF growth 5Y4.72%